The Discounted Cash Flow (DCF) valuation of Rigel Pharmaceuticals Inc (RIGL) is (46.93) USD. With the latest stock price at 19.01 USD, the upside of Rigel Pharmaceuticals Inc based on DCF is -346.9%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.0% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (96.78) - (31.54) | (46.93) |
| Upside | -609.1% - -265.9% | -346.9% |